Timeline:
2004: Professor Lakhani takes up positions in UQ’s School of Medicine (Head of the Discipline of Molecular and Cellular Pathology), Pathology Queensland (State Director of Anatomical Pathology), and UQ’s Centre for Clinical Research (UQCCR) (Head of the Molecular Breast Pathology Group)
2005: Establishes the Brisbane Breast Bank (BBB) in collaboration with the RBWH Breast Unit
2007: With Professors Georgia Chenevix-Trench and Kum Kum Khanna from QIMR-Berghofer, is successful in bid for National Health and Medical Research Council (NHMRC) program funding for Pathways to breast cancer development
2012: Is awarded NHMRC project grant for Defining therapeutic options for brain metastases, and NHMRC program funding is renewed for Molecular determinants of susceptibility and progression in breast cancer (UQ-QIMRB)
2015: Receives Distinguished Pathologist Award from the International Academy of Pathology (Australasian Division)
2015: Is awarded pilot funding from UQ and ANZ Breast Cancer Trials Group (ANZBCTG) for Repurposing HER2/3 antibodies for treatment of brain metastases from breast cancer (with Professor Andrew Scott, Olivia Newton-John Cancer Research Institute)
2016: Is awarded the Robert Sutherland Award for Excellence in Translational Research from ANZBCTG
2016: Receives Distinguished Fellow Award from the Royal College of Pathologists of Australasia, for outstanding contributions to pathology research, teaching and administration
2016: Is awarded seed funding from Metro North Hospital and Health Service for Improving treatments for brain metastases through advanced imaging (BoNSAI)
2017: Is successful in bid for third successive NHMRC program grant, Translating molecular determinants of susceptibility and progression in breast cancer (UQ-QIMRB)
2017: With Professors Greg Monteith and Sarah Roberts-Thomson and Dr Jodi Saunus, is awarded funding from US Department of Defense Congressionally Directed Medical Research Programs for Exploiting the remodelling of Ca2+ signalling in breast cancer cell microenvironments to control metastasis and to specifically target brain metastases
2017: Is selected for The William O Russell Lectureship and honoured with the Joanne Vandenberge Hill Award in Anatomical Pathology at the MD Anderson Cancer Centre, Texas, USA
(Photo credit this page: Stewart Gould; Opening page: Drs Andrew Dalley and Jodi Saunus, UQCCR Molecular Breast Pathology, and adjusted by Craig Oddy, Office of Marketing and Communications)